home / stock / inmb / inmb quote
Last: | $ |
---|---|
Change Percent: | 3.27% |
Open: | $5.00 |
Close: | $5.05 |
High: | $5.30 |
Low: | $4.8001 |
Volume: | 22,030 |
Last Trade Date Time: | 02/12/2020 04:40:27 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $5.00 | $5.05 | $5.30 | $4.8001 | 22,030 | 02-12-2020 |
$ | $5.15 | $4.89 | $5.20 | $4.89 | 12,979 | 02-11-2020 |
$ | $4.96 | $5.075 | $5.25 | $4.85 | 35,299 | 02-10-2020 |
$ | $5.05 | $4.9851 | $5.09 | $4.876 | 17,276 | 02-07-2020 |
$ | $5.39 | $5.0272 | $5.40 | $4.90 | 17,544 | 02-06-2020 |
$ | $4.90 | $4.90 | $5.1031 | $4.90 | 7,740 | 02-05-2020 |
$ | $4.8441 | $4.7811 | $4.9123 | $4.70 | 15,667 | 02-04-2020 |
$ | $4.94 | $4.75 | $4.9531 | $4.75 | 12,019 | 02-03-2020 |
$ | $4.8614 | $4.93 | $5.00 | $4.85 | 4,282 | 01-31-2020 |
$ | $4.80 | $4.78 | $4.80 | $4.77 | 5,549 | 01-30-2020 |
$ | $5.2746 | $4.9198 | $5.2746 | $4.9198 | 8,917 | 01-29-2020 |
$ | $4.9785 | $5.1354 | $5.1354 | $4.9224 | 4,522 | 01-28-2020 |
$ | $5.03 | $4.82 | $5.0539 | $4.70 | 6,074 | 01-27-2020 |
$ | $5.24 | $4.995 | $5.24 | $4.98 | 19,577 | 01-24-2020 |
$ | $5.29 | $4.95 | $5.32 | $4.75 | 34,088 | 01-23-2020 |
$ | $5.6777 | $5.2502 | $5.6777 | $5.25 | 20,294 | 01-22-2020 |
$ | $5.58 | $5.60 | $5.6216 | $5.52 | 11,951 | 01-21-2020 |
$ | $5.68 | $5.66 | $5.7134 | $5.65 | 10,117 | 01-20-2020 |
$ | $5.68 | $5.66 | $5.7134 | $5.65 | 10,117 | 01-17-2020 |
$ | $5.6101 | $5.68 | $5.8382 | $5.57 | 13,358 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Boca Raton, Florida, April 23, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is delighted to announce the suc...
2024-04-22 11:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Boca Raton, Florida, April 22, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced today t...